Filed: 2/17/2026ACC: 0001958125-26-000002
๐ What this filing means
CATALIO CAPITAL MANAGEMENT, LP filed this quarterly 13FโHR report disclosing 45 equity positions with a total reported market value of $565.79M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
45
Positions
$565.79M
Total AUM (reported)
21.33M
Total Shares
Allocation by class
COM$415.62M73.5%
COM NEW$64.89M11.5%
SPONSORED ADS$30.87M5.5%
SPONSORED ADR$25.43M4.5%
COMMON STOCK$10.18M1.8%
COM STK$7.71M1.4%
SHS$7.71M1.4%
Portfolio Concentration
Top 3$104.82M18.5%
4โ10$184.79M32.7%
11โ25$202.09M35.7%
Rest$74.08M13.1%
Top 3 weight
18.5%
Top 10 weight
51.2%
Voting Authority Distribution
Total shares with voting rights: 21.33M
Sole
Full voting authority
21.33M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole45
Shared0
Other0
Dominant voting typeSole ยท 100.0% of voting shares
Institutional Holdings45
Rows:
GILEAD SCIENCES INC
SOLEShares289.31K
TypeSH
Market value$35.51M
6.28%
Sole
289.31K
Shared
0.00
None
0.00
BRISTOL-MYERS SQUIBB CO
SOLEShares647.90K
TypeSH
Market value$34.95M
6.18%
Sole
647.90K
Shared
0.00
None
0.00
BOSTON SCIENTIFIC CORP
SOLEShares360.43K
TypeSH
Market value$34.37M
6.07%
Sole
360.43K
Shared
0.00
None
0.00
BRIDGEBIO ONCOLOGY THERAPEUT
SOLEShares410.70K
TypeSH
Market value$31.41M
5.55%
Sole
410.70K
Shared
0.00
None
0.00
ELI LILLY & CO
SOLEShares25.92K
TypeSH
Market value$27.86M
4.92%
Sole
25.92K
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares653.57K
TypeSH
Market value$26.93M
4.76%
Sole
653.57K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares119.27K
TypeSH
Market value$25.43M
4.49%
Sole
119.27K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares1.20M
TypeSH
Market value$25.14M
4.44%
Sole
1.20M
Shared
0.00
None
0.00
JOHNSON & JOHNSON
SOLEShares120.84K
TypeSH
Market value$25.01M
4.42%
Sole
120.84K
Shared
0.00
None
0.00
REGENERON PHARMACEUTICALS
SOLEShares29.80K
TypeSH
Market value$23.00M
4.07%
Sole
29.80K
Shared
0.00
None
0.00
STRUCTURE THERAPEUTICS INC
SOLEShares252.90K
TypeSH
Market value$17.59M
3.11%
Sole
252.90K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares360.34K
TypeSH
Market value$16.68M
2.95%
Sole
360.34K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares258.38K
TypeSH
Market value$16.42M
2.90%
Sole
258.38K
Shared
0.00
None
0.00
EDWARDS LIFESCIENCES CORP
SOLEShares187.05K
TypeSH
Market value$15.95M
2.82%
Sole
187.05K
Shared
0.00
None
0.00
INTUITIVE SURGICAL INC
SOLEShares27.21K
TypeSH
Market value$15.41M
2.72%
Sole
27.21K
Shared
0.00
None
0.00
NATERA INC
SOLEShares62.27K
TypeSH
Market value$14.27M
2.52%
Sole
62.27K
Shared
0.00
None
0.00
ADAPTIVE BIOTECHNOLOGIES COR
SOLEShares821.20K
TypeSH
Market value$13.34M
2.36%
Sole
821.20K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares98.51K
TypeSH
Market value$13.29M
2.35%
Sole
98.51K
Shared
0.00
None
0.00
SUPERNUS PHARMACEUTICALS INC
SOLEShares257.46K
TypeSH
Market value$12.80M
2.26%
Sole
257.46K
Shared
0.00
None
0.00
FRACTYL HEALTH INC
SOLEShares5.49M
TypeSH
Market value$12.08M
2.14%
Sole
5.49M
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares331.85K
TypeSH
Market value$12.04M
2.13%
Sole
331.85K
Shared
0.00
None
0.00
PHATHOM PHARMACEUTICALS INC
SOLEShares699K
TypeSH
Market value$11.60M
2.05%
Sole
699K
Shared
0.00
None
0.00
ADMA BIOLOGICS INC
SOLEShares564.46K
TypeSH
Market value$10.30M
1.82%
Sole
564.46K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares156.11K
TypeSH
Market value$10.18M
1.80%
Sole
156.11K
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares519.72K
TypeSH
Market value$10.17M
1.80%
Sole
519.72K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting โ Sole | Shared | None |
|---|---|---|---|---|---|---|---|
GILEAD SCIENCES INCSOLE | COM | 289.31K | SH | $35.51M 6.28% | 289.31K | 0.00 | 0.00 |
BRISTOL-MYERS SQUIBB COSOLE | COM | 647.90K | SH | $34.95M 6.18% | 647.90K | 0.00 | 0.00 |
BOSTON SCIENTIFIC CORPSOLE | COM | 360.43K | SH | $34.37M 6.07% | 360.43K | 0.00 | 0.00 |
BRIDGEBIO ONCOLOGY THERAPEUTSOLE | COM NEW | 410.70K | SH | $31.41M 5.55% | 410.70K | 0.00 | 0.00 |
ELI LILLY & COSOLE | COM | 25.92K | SH | $27.86M 4.92% | 25.92K | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 653.57K | SH | $26.93M 4.76% | 653.57K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 119.27K | SH | $25.43M 4.49% | 119.27K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 1.20M | SH | $25.14M 4.44% | 1.20M | 0.00 | 0.00 |
JOHNSON & JOHNSONSOLE | COM | 120.84K | SH | $25.01M 4.42% | 120.84K | 0.00 | 0.00 |
REGENERON PHARMACEUTICALSSOLE | COM | 29.80K | SH | $23.00M 4.07% | 29.80K | 0.00 | 0.00 |
STRUCTURE THERAPEUTICS INCSOLE | SPONSORED ADS | 252.90K | SH | $17.59M 3.11% | 252.90K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 360.34K | SH | $16.68M 2.95% | 360.34K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 258.38K | SH | $16.42M 2.90% | 258.38K | 0.00 | 0.00 |
EDWARDS LIFESCIENCES CORPSOLE | COM | 187.05K | SH | $15.95M 2.82% | 187.05K | 0.00 | 0.00 |
INTUITIVE SURGICAL INCSOLE | COM NEW | 27.21K | SH | $15.41M 2.72% | 27.21K | 0.00 | 0.00 |
NATERA INCSOLE | COM | 62.27K | SH | $14.27M 2.52% | 62.27K | 0.00 | 0.00 |
ADAPTIVE BIOTECHNOLOGIES CORSOLE | COM | 821.20K | SH | $13.34M 2.36% | 821.20K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 98.51K | SH | $13.29M 2.35% | 98.51K | 0.00 | 0.00 |
SUPERNUS PHARMACEUTICALS INCSOLE | COM | 257.46K | SH | $12.80M 2.26% | 257.46K | 0.00 | 0.00 |
FRACTYL HEALTH INCSOLE | COM | 5.49M | SH | $12.08M 2.14% | 5.49M | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 331.85K | SH | $12.04M 2.13% | 331.85K | 0.00 | 0.00 |
PHATHOM PHARMACEUTICALS INCSOLE | COM | 699K | SH | $11.60M 2.05% | 699K | 0.00 | 0.00 |
ADMA BIOLOGICS INCSOLE | COM | 564.46K | SH | $10.30M 1.82% | 564.46K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 156.11K | SH | $10.18M 1.80% | 156.11K | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 519.72K | SH | $10.17M 1.80% | 519.72K | 0.00 | 0.00 |
Page 1 of 2